Table 2.
Cardiometabolic risk markers and peripheral insulin sensitivity by NEFA suppression tertile
| Outcome | Low Suppression (n=15) | Moderate Suppression (n=17) | High Suppression (n=15) | p-value |
|---|---|---|---|---|
| Triglycerides(mmol/L) | 2.40 (0.26)a,b | 1.52 (0.24)b | 0.79 (0.25) | 0.0001 |
| HDL (mmol/L) | 1.18 (0.12) | 1.06 (0.11) | 1.22 (0.12) | 0.35 |
| LDL (mmol/L) | 2.86 (0.14)a,b | 2.07 (0.13) | 2.09 (0.14) | 0.0002 |
| IL6 (pg/ml) | 4.09 (0.75) | 3.39 (0.71) | 2.69 (0.79) | 0.45 |
| hsCRP (nmol/L) | 71.5 (13.2) | 78.0 (12.2) | 83.2 (13.6) | 0.71 |
| GIR (mg/kg*m−1) | 7.46 (1.10) | 7.94 (1.00) | 8.79 (1.07) | 0.50 |
| Lean GIR (mg/lean kg*min−1) | 11.58 (1.59) | 12.05 (1.45) | 12.86 (1.62) | 0.74 |
| SBP (mmHg) | 124.8 (3.78) | 119.2 (3.51) | 118.8 (3.91) | 0.28 |
| DBP (mmHg) | 73.3 (1.97) | 69.7 (1.85) | 70.5 (1.99) | 0.40 |
| Log(ALT) | 4.07 (0.17)a,b | 3.46 (0.16) | 3.40 (0.17) | 0.02 |
| Adiponectin (μ/ml) | 7.35 (1.44) | 7.55 (1.19) | 7.49 (1.27) | 0.98 |
Data represent estimated Means (SD) from the regression analyses, controlling for covariates as described in the methods
a
Significant vs. moderate suppression;
b
Significant vs. high suppression